SCHEMBL11200218

SCHEMBL11200218

CC(C)NCC(O)COc1ccccc1C#N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 4/20 0.70
HTR1A P08908 4/20 0.70
ADRA2A P08913 2/20 0.70
ADRA2B P18089 1/20 0.70
MAOA P21397 1/20 0.70
ADRB2 P07550 11/20 0.66
ADRB1 P08588 11/20 0.66
ADRB3 P13945 4/20 0.66
CYP1A2 P05177 4/20 0.61
CYP2D6 P10635 4/20 0.61
SLC6A4 P31645 4/20 0.61
SIGMAR1 Q99720 4/20 0.61
HTR2A P28223 4/20 0.61
NR2E1 Q9Y466 3/20 0.61
ALDH1A1 P00352 3/20 0.61
HTR2C P28335 3/20 0.61
HTR6 P50406 3/20 0.61
LMNA P02545 3/20 0.61
SCN1A P35498 2/20 0.61
SLC10A1 Q14973 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11207616 0.89 HTR1A (0.67) HTR2BHTR1AADRA2AADRA2BMAOA
SCHEMBL11751333 0.88 HTR1A (0.65) HTR2BHTR1AADRA2AADRA2BMAOA
SCHEMBL11197802 0.86 ADRB2 (0.66) HTR2BHTR1AADRA2AADRB2ADRB1
SCHEMBL11868102 0.85 ADRB2 (0.82) HTR2BHTR1AADRA2AADRB2ADRB1
SCHEMBL11748169 0.85 HTR1A (0.68) HTR2BHTR1AADRA2AADRA2BMAOA
SCHEMBL10594381 0.84 ADRB2 (0.63) HTR2BHTR1AADRA2AADRB2ADRB1
Hydrochloric Acid SCHEMBL11874444 0.84 ADRB2 (0.80) HTR2BHTR1AADRA2AADRB2ADRB1
SCHEMBL9655212 0.83 HTR1A (0.70) HTR2BHTR1AADRA2AADRA2BMAOA
SCHEMBL11751117 0.83 HTR1A (0.62) HTR2BHTR1AADRA2AADRA2BMAOA
SCHEMBL11071495 0.83 MEN1 (0.67) HTR2BHTR1AADRA2AADRA2BMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4391980-A FOR INVERSION OF CONFIGURATION OF OPTICALLY ACTIVE COMPOUNDS CIBA-GEIGY CORPORATION (US) 1983-07-05 US disclosed
US-4294966-A SALT FORMATION CIBA-GEIGY CORPORATION (US) 1981-10-13 US disclosed
EP-0007605-A1 A process for inverting the configuration in optically active compounds and optically active intermediate compounds and their salts required therefor CIBA-GEIGY AG (CH) 1980-02-06 EP disclosed
US-4182911-A BETA-ADRENERGIC BLOCKING AGENTS IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-01-08 US disclosed
US-4161530-A CYCLIC SUBSTITUTED AMINO ALCOHOL BETA-RECEPTOR-BLOCKING AGENT AND TRYPTOPHANE CIBA-GEIGY CORPORATION (US) 1979-07-17 US disclosed
US-3975539-A B-ADRENERGIC BLOCKING, HYPOTENSIVE BOEHRINGER INGELHEIM GMBH (DT) 1976-08-17 US disclosed
US-3937834-A ALPHA-RECEPTOR BLOCKER, BETA-RECEPTOR BLOCKER, HIGH BLOOD PRESSURE, ANGINA PECTORIS CIBA-GEIGY CORPORATION (US) 1976-02-10 US disclosed